Related references
Note: Only part of the references are listed.Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice
Lazaro Gil et al.
JOURNAL OF GENERAL VIROLOGY (2012)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Alan L. Rothman
NATURE REVIEWS IMMUNOLOGY (2011)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus
Carlos Lopez et al.
ARCHIVES OF VIROLOGY (2009)
Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
Laura Lazo et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice
Lazaro Gil et al.
INTERNATIONAL IMMUNOLOGY (2009)
The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis Model
Lazaro Gil et al.
VIRAL IMMUNOLOGY (2009)
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice
Iris Valdes et al.
VIROLOGY (2009)
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
Lidice Bernard et al.
ANTIVIRAL RESEARCH (2008)
Mouse models of dengue virus infection and disease
Lauren E. Yauch et al.
ANTIVIRAL RESEARCH (2008)
A Complex Interplay among Virus, Dendritic Cells, T Cells, and Cytokines in Dengue Virus Infections
Wanwisa Dejnirattisai et al.
JOURNAL OF IMMUNOLOGY (2008)
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
Jennifer L. Kyle et al.
VIROLOGY (2008)
Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus
Alienys Izquierdo et al.
VIRUS RESEARCH (2008)
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein Vaccines in rhesus macaques
Monika Simmons et al.
JOURNAL OF VIROLOGY (2006)
Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
L Hermida et al.
VACCINE (2006)
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, Whereas T- and B-cell-dependent immunity are less critical
S Shresta et al.
JOURNAL OF VIROLOGY (2004)
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
A Sabchareon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs
A Zulueta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Technical and regulatory hurdles for DNA vaccines
J Donnelly et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain
P Riedl et al.
JOURNAL OF IMMUNOLOGY (2002)
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: Role of serotype concentration, ratio, and multiple doses
A Sabchareon et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells
F Takeshita et al.
JOURNAL OF IMMUNOLOGY (2001)
Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large
I Kurane et al.
REVIEWS IN MEDICAL VIROLOGY (2001)
Chimeric yellow fever/dengue virus as a candidate dengue vaccine: Quantitation of the dengue virus-specific CD8 T-cell response
RG Van Der Most et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
